Nanion Technologies GmbH hires Dr. Cecilia Farre to strengthen the ion channel expert team
16-Jan-2006
After a successful introduction of Nanion's first generation of automated patch clamp devices, the company seeks to expand its team and hired Cecilia Farre, Ph.D., for research, product development as well as marketing and sales activities.
Dr. Cecilia Farre graduated in analytical chemistry and electrophysiology from Göteborg University, Sweden, where she also held a postdoctoral position in electrophysiology. Dr. Farre was employed as project manager and later on Vice President of Key Projects at Cellectricon AB, Göteborg, Sweden, where she played a key role in the development and commercialization of the company's microfluidics platform.
Other news from the department people
Most read news
More news from our other portals
Last viewed contents
Study finds breast and ovarian cancer may have similar origins
Evonik ends cooperation with Chr. Hansen
Category:Female_sexual_dysfunction_drugs
Frederick W. Alt and David G. Schatz to be awarded the 2023 Paul Ehrlich and Ludwig Darmstaedter Prize - Laureates raised knowledge of the development of the immune system to a new level
Chemotherapy timing is key to success - Nanoparticles that stagger delivery of 2 drugs knock out aggressive tumors in mice
Call for Entries: Eppendorf & Science Prize for Neurobiology 2017
“Viral relicts” in the Genome Could Fuel Neurodegeneration - Researchers see ancient genes as potential targets for dementia treatment
BASF opens its $33 million facility expansion in Research Triangle Park, North Carolina, USA - State of the art research facilities enable further innovation in crop protection and plant biotechnology
Sanofi invests in new vaccine production facility in France
Monoamine oxidase A: biomarker for postpartum depression - Postpartum mood swings correlated with high monoamine oxidase A binding
Study links vitamin D to lung cancer survival - U-M researchers find high levels of enzyme that blocks vitamin D can predict lung cancer survival, U-M study finds
